False positives hamper lung CAD sensitivity
Computer-aided detection systems have proved beneficial for detecting lung nodules, but how do they fare in helping radiologists identify lung cancer? Not too well, according to a study presented at the European Congress of Radiology by a team of researchers from various institutions in South Korea.
Computer-aided detection systems have proved beneficial for detecting lung nodules, but how do they fare in helping radiologists identify lung cancer? Not too well, according to a study presented at the European Congress of Radiology by a team of researchers from various institutions in South Korea.
Led by Dr. Jin Mo Goo, investigators evaluated 150 chest CT exams that included 23 lung cancers less than 20 mm in size as well as normal cases.
Five chest radiologists and five radiology residents independently recorded the locus of each nodule candidate and assigned confidence scores to each based on likelihood of nodule and malignancy without CAD. They then repeated analysis with CAD.
Lung nodule detection significantly increased with CAD for all radiologists and subgroups of chest radiologists and radiology residents. CAD itself detected 18 of 23 lung cancers. Four lung cancers missed by three radiology residents on initial reading were additionally detected with CAD.
However, because the number of false-positive detections for lung cancer increased with the use of CAD, the overall performance of lung cancer detection was not significantly different with and without CAD for all radiologists and subgroups, according to Goo.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
